The US bioeconomy is worth $950 billion, and growing, thanks to these federal policies
Biotechnology — or the use of technology to convert plant and biological material into commodities — is not new. Doug Friedman, CEO of BioMADE, the Bioindustrial Manufacturing Innovation Institute, and…